MedPath

This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)

Phase 3
Active, not recruiting
Conditions
Multiple Sclerosis
Interventions
Registration Number
NCT03599245
Lead Sponsor
Hoffmann-La Roche
Brief Summary

This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who were previously enrolled in a F. Hoffmann-La Roche (Roche) sponsored ocrelizumab phase IIIb/IV trial (i.e. the Parent, P-trial).

Detailed Description

This is a single arm, open label, multicenter extension study in participants who completed treatment period with ocrelizumab in the Roche P-trials. Participants will receive treatment with ocrelizumab as single 600 mg infusions every 24 weeks for two years.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
1500
Inclusion Criteria
  • Signed Informed Consent Form
  • Able to comply with the study protocol, in the investigator's judgment
  • Completed the treatment period of Roche sponsored ocrelizumab P-trials
Exclusion Criteria
  • Hypersensitivity to ocrelizumab or to any of its excipients.
  • Participantss in a severely immunocompromised state until the condition resolves.
  • Evidence of any adverse event potentially attributable to ocrelizumab, for which the local label recommends permanent discontinuation.
  • Existence of a contra-indication as per SmPC
  • Prohibited concomitant medication as specified in protocol
  • Participants intending to become pregnant during the study or within 6 months after the last dose of the study drug in the parent study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
OcrelizumabOcrelizumabParticipants will receive a single 600-mg infusion of Ocrelizumab every 24 weeks up to Week 72 of this study.
Primary Outcome Measures
NameTimeMethod
Mean change from inclusion in parent study in EDSS score over the course of the treatmentUp to 2 years
Time to onset of CDP sustained for at least 24 weeks and for at least 48 weeksUp to 2 Years
Percentage of participants who have confirmed disability improvement (CDI), CDP for at least 24 weeks and for at least 48 weeks yearly and over the duration of the treatmentUp to 2 years
Percentage of participants who have improved, stable or worsened disability compared with baselineUp to 2 years

Improved, stable or worsened disability is measured by expanded disability status scale (EDSS) (annually/by epoch and over duration of the study) Stable EDSS is defined as EDSS change +/- 0.5. Worsening is \> 0.5 increase of EDSS, Improvement is \>0.5 decrease of EDSS

Time to 20% increase in timed 25-foot walk test (T25FWT)Up to 2 years

Time to 20% increase in timed nine-hole peg test (9HPT) sustained for at least 24 weeks and for at least 48 weeks, and proportion of patients achieving a sustained increase assessed yearly and at the end treatment

Secondary Outcome Measures
NameTimeMethod
Time to first protocol-defined event of disease activityUp to 2 Years
Time to first relapseUp to 2 Years
Annualized relapse rateUp to 2 Years
Percentage of participants relapse free, yearly and over the course of the treatmentUp to 2 Years
Percentage of participants with no evidence of protocol-defined disease activity (NEDA) yearly and over the duration of the treatmentUp to 2 Years

Disease activity is defined as at least one the following events: protocol-defined relapse; 24 weeks CDP based on increases in EDSS; a T1 Gadolinium (Gd)-enhanced lesion; or a new and/or enlarging T2 hyperintense lesion on magnetic resonance imaging (MRI).

Percentage of participants with no evidence of progression (NEP)Up to 2 Years

NEP is defined as no progression sustained for at least 24 weeks on all of the following three components (CDP; 20% increase in timed T25FWT; 20% increase in timed 9HPT yearly and over the course of the treatment

Presence and evolution of leptomeningeal follicles as detected by MRIUp to 2 Years
Percentage of participants with no evidence of progression sustained for at least 24 weeks and no active disease (NEPAD)Up to 2 Years

NEPAD is defined as no progression on all of the three components of NEP (CDP, T25FWT, 9HPT), no new relapse and no enlarging or new T2 or T1 Gd-enhancing lesion yearly and over the course of the treatment

Change from baseline in cognitive performance as measured by the Symbol digit modalities test (SDMT)Up to 2 Years
Total number of new and/or enlarging T2 lesion as detected by brain MRI over timeUp to 2 Years
Change in total T1 hypointense lesion volume over timeUp to 2 Years
Total number of T1 Gd-enhancing lesions as detected by brain MRI over timeUp to 2 Years
Participant reported outcomes: SymptoMScreen ScoreUp to 2 Years
Participant reported outcomes: Quality of life (QoL) (Multiple Sclerosis Impact Scale [MSIS]-29)Up to 2 Years
Percentage of Participants with Adverse EventsUp to 2 Years
Total number of fluid-attenuated inversion-recovery (FLAIR) late enhancing lesions as detected by brain MRI over timeUp to 2 Years
Change in brain volume (grey and white matter) as detected by brain MRI over timeUp to 2 Years
Time to treatment discontinuation/switchUp to 2 Years
Participant reported outcomes: Employment status (Work Productivity and Activity Impairment Questionnaire [WPAI])Up to 2 Years
Total number of FLAIR late enhancing lesions as detected by brain MRI at the end of the treatment periodUp to 2 years

Trial Locations

Locations (161)

Instituto de Neurologia de Curitiba

🇧🇷

Curitiba, Paraná, Brazil

Hospital Sao Lucas - PUCRS

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

Hospital das Clinicas - FMUSP

🇧🇷

Sao Paulo, São Paulo, Brazil

Shat Np Sveti Naum

🇧🇬

Sofia, Bulgaria

Hopital Gabriel Montpied CHU de Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

CH de Gonesse

🇫🇷

Gonesse, France

CHU de Grenoble

🇫🇷

La Tronche, France

Hopital Roger Salengro Service de Neurologie

🇫🇷

Lille, France

CHU de Nîmes Hopital Caremeau

🇫🇷

Nimes, France

CHU de la Timone - Hopital d Adultes

🇫🇷

Marseille, France

Hopital Gui de Chauliac

🇫🇷

Montpellier, France

Hôpital Guillaume et René Laënnec

🇫🇷

Nantes, France

Hopital Central - CHU de Nancy

🇫🇷

Nancy, France

Hôpital Pasteur

🇫🇷

Nice, France

Groupe Hospitalier Pitié- Salpétrière

🇫🇷

Paris, France

Hôpital de Poissy

🇫🇷

Poissy, France

CHU de Rouen Hopital

🇫🇷

Rouen, France

Höpital Hautepierre

🇫🇷

Strasbourg, France

HIA de Toulon hôpital militaire

🇫🇷

Toulon, France

St Vincents University Hospital

🇮🇪

Dublin 4, Ireland

Budapesti Jahn Ferenc Dél-pesti Kórház és Rendel?intézet

🇭🇺

Budapest, Hungary

VALEOMED Diagnosztikai Központ

🇭🇺

Esztergom, Hungary

Ospedale SS. Annunziata - Clinica Neurologica - Centro Sclerosi Multipla

🇮🇹

Chieti, Abruzzo, Italy

Ospedale San Salvatore

🇮🇹

L'Aquila, Abruzzo, Italy

A. O. U. Federico II

🇮🇹

Napoli, Campania, Italy

AO Ospedali Riuniti Villa Sofia-Cervello

🇮🇹

Palermo, Sicilia, Italy

AOU Careggi

🇮🇹

Firenze, Toscana, Italy

AOUC Azienda Ospedaliero-Universitaria Careggi

🇮🇹

Firenze, Toscana, Italy

AOU Senese - Presidio Ospedaliero Le Scotte

🇮🇹

Siena, Toscana, Italy

AO di Perugia - Ospedale S. Maria della Misericordia

🇮🇹

Perugia, Umbria, Italy

Azienda Ospedaliera di Padova

🇮🇹

Padova, Veneto, Italy

Policlinico G.B. Rossi

🇮🇹

Verona, Veneto, Italy

Ibn Sina Hospital

🇰🇼

Kuwait, Kuwait

Hospital Universitari de Bellvitge

🇪🇸

L'Hospitalet de Llobregat, Barcelona, Spain

Hospital General de Castellon

🇪🇸

Castelló de la Plana, Castellon, Spain

Complejo Hospitalario Universitario A Coruña (CHUAC)

🇪🇸

Coruña, LA Coruna, Spain

Hospital Universitari Arnau de Vilanova de Lleida

🇪🇸

Lleida, Lerida, Spain

Hospital Quiron de Madrid

🇪🇸

Pozuelo de Alarcon, Madrid, Spain

Complejo Hospitalario Universitario de Vigo - Xeral Cies

🇪🇸

Vigo, Pontevedra, Spain

Hospital Vall d'Hebron

🇪🇸

Barcelona, Spain

Hospital Puerta del Mar

🇪🇸

Cadiz, Spain

Hospital Universitari de Girona Dr. Josep Trueta

🇪🇸

Girona, Spain

Universitario de La Princesa

🇪🇸

Madrid, Spain

Hospital Universitario Clínico San Carlos

🇪🇸

Madrid, Spain

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

Hospital Universitario Virgen de Arrixaca

🇪🇸

Murcia, Spain

Hospital Universitario Virgen Macarena

🇪🇸

Sevilla, Spain

Hospital Clinico Universitario de Valencia

🇪🇸

Valencia, Spain

Hospital Universitario la Fe

🇪🇸

Valencia, Spain

Sahlgrenska Sjukhuset

🇸🇪

Göteborg, Sweden

Centralsjukhuset

🇸🇪

Karlstad, Sweden

Centrum för Neurologi

🇸🇪

Stockholm, Sweden

Hacettepe University Medical Faculty

🇹🇷

Ankara, Turkey

Gazi University Medical Faculty

🇹🇷

Ankara, Turkey

Mustafa Kemal Ataturk UTF

🇹🇷

Hatay, Turkey

Istanbul University Istanbul School of Medicine

🇹🇷

Istanbul, Turkey

Istanbul Universitesi - Cerrahpasa Cerrahpasa Tip Fakultesi

🇹🇷

Istanbul, Turkey

Selcuk University Medical Faculty

🇹🇷

Konya, Turkey

Ondokuz Mayis University School of Medicine

🇹🇷

Samsun, Turkey

Karadeniz Tecnical Uni. Med. Fac.

🇹🇷

Trabzon, Turkey

Royal Devon and Exeter Hospital (Wonford)

🇬🇧

Exeter, United Kingdom

Queen Elizabeth University Hospital

🇬🇧

Glasgow, United Kingdom

Raigmore Hospital

🇬🇧

Inverness, United Kingdom

Kings College Hospital

🇬🇧

London, United Kingdom

AZ Sint Jan

🇧🇪

Brugge, Belgium

UZ Antwerpen

🇧🇪

Edegem, Belgium

CHU Tivoli

🇧🇪

La Louvière, Belgium

CHU Sart-Tilman

🇧🇪

Liège, Belgium

Revalidatie en MS Centrum

🇧🇪

Overpelt, Belgium

Hopital neurologique Pierre Wertheimer - CHU Lyon

🇫🇷

Bron, France

St George's Hospital

🇬🇧

London, United Kingdom

Charing Cross Hospital

🇬🇧

London, United Kingdom

Royal Victoria Infirmary

🇬🇧

Newcastle upon Tyne, United Kingdom

Salford Royal NHS Foundation Trust

🇬🇧

Salford, United Kingdom

Royal Hallamshire Hospita

🇬🇧

Sheffield, United Kingdom

Morriston Hospital

🇬🇧

Swansea, United Kingdom

Royal Cornwall Hospital

🇬🇧

Truro, United Kingdom

Hospital Churruca Visca

🇦🇷

Buenos Aires, Argentina

Centro de Especialidades Neurológicas y Rehabilitación - CENyR

🇦🇷

Ciudad Autonoma Buenos Aires, Argentina

Fundacion Rosarina de Neurorehabilitacion

🇦🇷

Rosario, Argentina

Multiprofile Hosp. for Active Treatment

🇧🇬

Sofia, Bulgaria

University of British Columbia

🇨🇦

Vancouver, British Columbia, Canada

London Health Sciences Centre Uni Campus

🇨🇦

London, Ontario, Canada

The Ottawa Hospital - General Campus

🇨🇦

Ottawa, Ontario, Canada

Sunnybrook Health Sciences Centre

🇨🇦

Toronto, Ontario, Canada

Clinique NeuroOutaouais

🇨🇦

Gatineau, Quebec, Canada

Recherche Sepmus Inc.

🇨🇦

Greenfield Park, Quebec, Canada

Montreal Neurological Institute and Hospital

🇨🇦

Montreal, Quebec, Canada

Clinical Hospital Centre Zagreb

🇭🇷

Zagreb, Croatia

Fakultni nemocnice u sv. Anny

🇨🇿

Brno, Czechia

Nemocnice Jihlava

🇨🇿

Jihlava, Czechia

VFN Praha Poliklinika Rs Centrum - Budova A

🇨🇿

Prague, Czechia

Fakultni nemocnice v Motole

🇨🇿

Praha 5, Czechia

Aalborg Universitetshospital

🇩🇰

Aalborg, Denmark

Aarhus Universitetshospital

🇩🇰

Aarhus N, Denmark

Rigshospitalet Glostrup

🇩🇰

Glostrup, Denmark

Odense Universitetshospital, Neurologisk Afdeling N

🇩🇰

Odense C, Denmark

Hjerne- og nervesygdomme, Ambulatorium, Skleroseklinikken

🇩🇰

Sønderborg, Denmark

East Tallinn Central Hospital

🇪🇪

Tallinn, Estonia

West Tallinn Central Hospital

🇪🇪

Tallinn, Estonia

Tartu University Hospital

🇪🇪

Tartu, Estonia

Mehiläinen Neo Turku

🇫🇮

Turku, Finland

CHU de Besancon Hopital Jean Minjoz

🇫🇷

Besançon, France

Groupe Hospitalier Pellegrin

🇫🇷

Bordeaux, France

Università degli Studi della Campania Luigi Vanvitelli

🇮🇹

Napoli, Campania, Italy

Ospedale Bellaria

🇮🇹

Bologna, Emilia-Romagna, Italy

Policlinico Tor Vergata Dip. Neuroscienze-Clinica Neurologica-UOSD Sclerosi Multipla

🇮🇹

Roma, Lazio, Italy

Ospedale S.Camillo Forlanini

🇮🇹

Roma, Lazio, Italy

Policlinico Universitario A. Gemelli

🇮🇹

Roma, Lazio, Italy

Azienda Ospedaliera Sant'Andrea

🇮🇹

Roma, Lazio, Italy

Irccs A.O.U.San Martino Ist

🇮🇹

Genova, Liguria, Italy

ASST PAPA GIOVANNI XXIII Neurologia USS Malattie Autoimmuni Centro Sclerosi Multipla

🇮🇹

Bergamo, Lombardia, Italy

Ospedale S.Antonio Abate

🇮🇹

Gallarate, Lombardia, Italy

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico

🇮🇹

Milano, Lombardia, Italy

IRCCS Ospedale San Raffaele

🇮🇹

Milano, Lombardia, Italy

Fond. Istituto Neurologico C.Besta

🇮🇹

Milano, Lombardia, Italy

Ospedale Civile di Montichiari

🇮🇹

Montichiari, Lombardia, Italy

IRCCS Istituto Neurologico C. Mondino?Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla

🇮🇹

Pavia, Lombardia, Italy

AOU Ospedali Riuniti Umberto I-G.M. Lancisi-G. Salesi

🇮🇹

Ancona, Marche, Italy

IRCCS Istituto Neurologico Neuromed

🇮🇹

Pozzilli, Molise, Italy

IRCCS Ospedale Casa Sollievo Della Sofferenza

🇮🇹

San Giovanni Rotondo, Puglia, Italy

Ospedale Binaghi

🇮🇹

Cagliari, Sardegna, Italy

AOU Policlinico V. Emanuele - P.O G. Rodolico

🇮🇹

Catania, Sicilia, Italy

Fondazione Istituto S. Raffaele - Giglio

🇮🇹

Cefalù, Sicilia, Italy

AOU Policlinico Giaccone

🇮🇹

Palermo, Sicilia, Italy

Hospital General de México

🇲🇽

Mexico City, Mexico CITY (federal District), Mexico

Hospital Angeles de Culiacán, Neurociencias Estudios Clínicos SC

🇲🇽

Culiacán, Sinaloa, Mexico

Unidad de investigacion en salud (UIS)

🇲🇽

Ciudad de México, Mexico

Jeroen Bosch Ziekenhuis

🇳🇱

'S Hertogenbosch, Netherlands

Amsterdam UMC Location VUMC

🇳🇱

Amsterdam, Netherlands

Amphia Ziekenhuis

🇳🇱

Breda, Netherlands

Groene Hart Ziekenhuis

🇳🇱

Gouda, Netherlands

Maasstadziekenhuis

🇳🇱

NL -rotterdam, Netherlands

Zuyderland Medisch Centrum - Sittard Geleen

🇳🇱

Sittard-Geleen, Netherlands

Elisabeth-TweeSteden Ziekenhuis

🇳🇱

Tilburg, Netherlands

Haukeland universitetssykehus

🇳🇴

Bergen, Norway

Sykehuset Buskerud HF

🇳🇴

Drammen, Norway

Stavanger Universitetssykehus, Helse Stavanger HF

🇳🇴

Stavanger, Norway

Neurocentrum Bydgoszcz sp. z o.o

🇵🇱

Bydgoszcz, Poland

COPERNICUS Podmiot Leczniczy Sp. z o. o. Szpital im. M. Kopernika

🇵🇱

Gdansk, Poland

Care Clinic

🇵🇱

Katowice, Poland

Malopolskie Centrum Diagnostyczne MEDICAL Sp. z o. o.

🇵🇱

Krakow, Poland

Centrum Neurologii Krzysztof Selmaj

🇵🇱

Lodz, Poland

Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak.

🇵🇱

Lublin, Poland

Klinika Neurologii I Wydzialu Lekarskiego WUM w Warszawie

🇵🇱

Warszawa, Poland

Instytut Psychiatrii i Neurologii II Klinika Neurologiczna

🇵🇱

Warszawa, Poland

Hospital de Braga

🇵🇹

Braga, Portugal

HUC

🇵🇹

Coimbra, Portugal

Hospital Beatriz Angelo

🇵🇹

Loures, Portugal

Hospital Geral de Santo Antonio

🇵🇹

Porto, Portugal

Univerzitna nemocnica Bratislava

🇸🇰

Bratislava, Slovakia

Univerzitna nemocnica Bratislava Nemocnica Ruzinov

🇸🇰

Bratislava, Slovakia

Fakultna nemocnica Trnava

🇸🇰

Trnava, Slovakia

University Medical Centre

🇸🇮

Ljubljana, Slovenia

University Medical Centre Maribor

🇸🇮

Maribor, Slovenia

Hospital Universitario Central de Asturias

🇪🇸

Oviedo, Asturias, Spain

Leeds Teaching Hospitals NHS Trust

🇬🇧

Leeds, United Kingdom

The Royal London Hospital

🇬🇧

London, United Kingdom

Royal Free Hospital

🇬🇧

London, United Kingdom

National Hospital for Neurology and Neurosurgery,

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath